Abstract
In spite of evidence that domestic and wild birds may act as carriers of human pathogenic fungi, data on the role of laying hens as reservoirs of drug resistant and virulent yeasts is lacking. Here, we assess several virulence factors (phospholipase and haemolysin activity) and the antifungal susceptibility profiles of 84 Candida albicans and 17 Candida catenulata strains isolated from cloacae (group A), faeces (group B) and eggs (group C) of laying hens. Of these strains, 95% C. albicans and 23% C. catenulata strains displayed phospholipase and haemolytic activities. For C. albicans, the highest values of phospholipase (Pz = 0.62) and haemolytic activities (Hz = 0.49) were recorded among the strains from group C whilst for C. catenulata (Pz = 0.54; Hz = 0.49) among those from group A. High minimum inhibitory concentration (MIC) values for azoles and amphotericin B (AmB) were recorded irrespective of their sources in all C. albicans strains. A total of 22 C. albicans strains were multidrug resistant, displaying resistance to fluconazole, itraconazole (ITZ), voriconazole (VOR) and posaconazole (POS). All C. catenulata strains from group C were resistant to ITZ, POS, micafungin and anidulafungin and susceptible to AmB. In this study, C. albicans and C. catenulata isolated from the cloacae, faeces and eggs of laying hens produced phospholipase and haemolysin and might be multidrug resistant. In the environment (faeces) or in eggs, C. albicans and C. catenulata strains might acquire pathogenic virulence traits and/or show multidrug resistance profiles. Based on these results, breeding and handling of laying hens and/or eggs may have implications for human and animal health.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Candida species are among the most common causes of infections, with overwhelming mortality rates in immunocompromised patients (Antinori et al. 2018; Tscherner et al. 2019). Candida spp. belong to the resident microbiota of the skin, mucosa and gastrointestinal tract of mammals including humans; in addition, domestic (Subramanya et al. 2017; Cafarchia et al. 2018) and wild birds (Brilhante et al. 2010; Brilhante et al. 2013) harbour and spread these yeasts in the environment via their faeces (Brilhante et al. 2010; Elhariri et al. 2015). Indeed, Candida albicans has been isolated from the gut, cloaca and droppings of domestic (e.g. laying hens, broiler chickens, pigeons) and wild (e.g. rhea, psittacinae, raptors, cockatiels) birds (Subramanya et al. 2017; Cafarchia et al. 2018; Brilhante et al. 2010). In addition, bird droppings act as a suitable substrate for the growth of Candida spp. due to intrinsically high concentrations of nitrogenous compounds (Elhariri et al. 2015). Yeasts such as Candida, Cryptococcus, Geotrichum, Rhodotorula and Trichosporon have also been isolated from environment, avian sources and eggs (Cafarchia et al. 2018). Interestingly, it has been demonstrated that laying hens might disseminate yeasts, mainly C. albicans and Candida catenulata, in the environment through eggs other than faeces (Cafarchia et al. 2018). At present, there is a growing concern that these yeasts species might acquire virulence determinants and antimicrobial resistance when moving between different niches (Tsiodras et al. 2008). Virulence factors such as secreted hydrolases (i.e. aspartyl proteases, phospholipases and haemolysins) play a pivotal role in the pathogenesis of Candida spp. infections (GunTang et al. 2017); the occurrence of such factors has been demonstrated in yeast strains, mainly C. albicans, isolated from the gut, cloaca and/or faeces of different avian species of synanthropic and pet birds or poultry (Cafarchia et al. 2008; Sidrim et al. 2010). Some of these yeasts also displayed a multidrug resistance profile (Brilhante et al. 2013; Sidrim et al. 2010; Lord et al. 2010; Brilhante et al. 2011; Brilhante et al. 2012), which has been associated, for fluconazole-resistance in particular, to the secretion of phospholipases (Ying and Chunyang 2012). In spite of the likely contribution of domestic and wild birds as carriers of human pathogenic fungi, no data is yet available on the role of laying hens as reservoirs of drug-resistant and virulent yeasts. Therefore, the present study aimed to assess (i) the production of hydrolytic enzymes such as phospholipase and haemolysin and (ii) the antifungal susceptibility profiles of C. albicans and C. catenulata isolated from the cloacae, faeces and eggs of laying hens.
Materials and methods
Fungal strains
A total of 101 strains of C. albicans (n = 84) and of C. catenulata (n = 17), previously isolated from the cloacae, faeces and eggs of laying hens (Cafarchia et al. 2018), were employed in this study. In particular, two or three Candida spp. strains per group in each positive shed were selected. C. catenulata was chosen since it has also been isolated from yolks and albumens of eggs (Cafarchia et al. 2018). The strains were assigned to three groups based on their origin. Group A included C. albicans (n = 67) and C. catenulata (n = 5) strains from cloacal swabs of laying hens; group B, C. albicans (n = 13) and C. catenulata (n = 4) strains from pools of faeces; and group C. C. albicans (n = 4) and C. catenulata (n = 8) strains from egg samples. The strains were isolated and identified based on colonial morphology, microscopic features, and by matrix-assisted laser desorption/ionisation time of flight mass spectrometry (MALDI-TOF MS), as previously reported (Cafarchia et al. 2018). Strains were stored at − 80 °C at the Department of Veterinary Medicine, University of Bari (Italy). Prior to testing, each strain was sub-cultured at least twice onto Sabouraud dextrose agar (SDA, Liofilchem, Italy) plates at 30 °C for 24–48 h to ensure strain purity and viability. All strains were molecularly confirmed by amplification and sequencing of the nuclear ribosomal ITS1-5.8S-ITS2 region.
In particular, genomic DNA was isolated from each strain using the DNeasy Blood & Tissue Kit (QIAGEN, Hilden, Germany), following manufacturer’s instructions. The nuclear ribosomal ITS1-5.8S-ITS2 region was amplified using ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) primers. The PCR reaction consisted of 4 μl genomic DNA (∼ 100 ng) and 46 μl of PCR mix containing 2.5 mM MgCl2, 10 mM Tris-HCl (pH 8.3) and 50 mM KCl, 250 μM of each dNTP, 100 pmol of each primer and 1.25 U of AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA), with an initial denaturation step of 10 min at 95 °C, followed by 35 cycles of denaturation for 1 min at 95 °C, annealing for 45 s at 55 °C, extension for 1 min 30 s at 72 °C and a final extension at 72 °C for 5 min. PCR products were examined on a 2% agarose gel stained with GelRed (VWR International PBI, Milano, Italy) and visualised on a Gel Logic 100 gel documentation system (Kodak, New York, USA). The amplicons were purified and sequenced in both directions using the Big Dye Terminator v.3.1 chemistry in a 3130 genetic analyser (Applied Biosystems, CA, USA). Sequences were aligned using the ClustalW program (Larkin et al. 2007) and compared with those available in GenBank by basic local alignment search tool (BLAST—http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Preparation of the yeast suspensions for the enzymatic activities
A loopful of the stock culture was streaked onto SDA and incubated at 37 °C for 24–48 h. Colonies were transferred into sterile saline solution and adjusted to an optical density of 1.3 using a turbidimeter (DEN-1McFarland Densitometer, Biosan) that was equivalent to 1.5 × 107 CFU/ml as validated by quantitative plate count of colony forming unit (CFU) in SDA.
Phospholipase activity
The production of phospholipase for Candida spp. was assessed using the egg-yolk plate method as previously described (Cafarchia et al. 2008; Price et al. 1982). A total of 10 μl yeast suspension was transferred onto egg-yolk plates and incubated at 32 °C for 5 days. The formation of a precipitation zone surrounding the colonies was considered as an indicator for enzyme production. The production of phospholipase (Pz) was expressed as a ratio of colony diameter by the total diameter of the colonies plus zone of precipitation (Price et al. 1982). Each strain was tested in duplicate, and the experiments were repeated over two consecutive days. The Pz values were reported as average of the values registered. The following ranges of activity according to the Pz index were established as follows: high, Pz ≤ 0.69; moderate, Pz = 0.70–0.89; weak, Pz = 0.90–0.99; none, Pz = 1 (Price et al. 1982).
Haemolytic activity
The haemolytic activity of Candida spp. was assessed by using SDA supplemented with 7% sheep blood and 3% glucose and adjusted to a pH of 5.6 ± 0.29. A total of 10 μl yeast suspension was inoculated in duplicate onto the media and incubated at 37 °C for 2 and 5 days, respectively. After incubation, a distinct translucent halo around the inoculation site indicated positive haemolytic activity (Elfeky and Gohar 2016). The ratio of the diameter of the colony (a) by that of the translucent zone (b) was used as value of the haemolytic index (Hz value) which represents the extent of haemolysin activity by the different C. albicans strains tested. Each strain was tested in duplicate, and the experiments were repeated over two consecutive days. The Hz values were reported as average of the values registered.
Antifungal susceptibility test
The sensitivity to antifungal drugs of C. albicans and C. catenulata strains was evaluated using broth microdilution (BMD) testing in accordance with the guidelines available in the CLSI document M27-A3 (CLSI 2008). The following antifungal drugs were supplied by the manufacturers as pure standard compounds: amphotericin B (AmB) and itraconazole (ITC) (Sigma-Aldrich Milan, Italy), fluconazole (FLC) and voriconazole (VOR) (Pfizer Pharmaceuticals; Groton, Connecticut, USA), posaconazole (POS) (Schering-Plough Corporation, Kenilworth, NJ, USA), anidulafungin (ANI) (Sigma-Aldrich, Milan, Italy) and micafungin (MCF) (Sigma-Aldrich; Milan, Italy). FLC was dissolved in sterile water, whereas the remaining drugs were solubilised in dimethyl sulfoxide-DMSO (Sigma-Aldrich, Milan, Italy). The concentration of each antifungal drug ranged from 0.016 to 32 mg/L, except for FLC (i.e. from 0.06 to 128 mg/L). Visual reading of plates was performed after 48-h incubation at 35 °C. All strains were tested in duplicate. For azoles, the minimum inhibitory concentration (MIC) endpoint was defined as the lowest concentration that produced a significant decrease in turbidity (≥ 50%) compared with that of drug-free control. For AmB, the MIC endpoint was defined as the minimum concentration at which no visible growth was detected. Control strains (Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258 of the American Type Culture Collection, Manassas, VA, USA) were included to evaluate the accuracy of drug dilutions and reproducibility of results (CLSI 2008). Data were reported as MIC range, mean MIC value (MICm) and MIC to which 50% (MIC50) and 90% (MIC90) strains were inhibited. The following breakpoints or epidemiological cut-off values (ECV) were used to categorise these Candida strains as sensitive (S), dose-dependent sensitive (SDD) or resistant (R) (Pfaller 2012a; CLSI 2018): FLC (S MIC ≤ 2 μg/mL, SDD MIC = 4–32 μg/mL, R MIC ≥ 8 μg/mL); ITZ (S MIC = 0.125 μg/mL, SDD MIC = 0.25–0.5 μg/mL, R MIC ≥ 1 μg/mL); POS (ECV MIC ≤ 0.06 μg/mL, R MIC ≥ 0.06 μg/mL); VOR (S MIC ≤ 0.125 μg/mL, SDD MIC = 0.25–0.5 μg/mL, R MIC ≥ μg/mL); MCF and ANI (S MIC ≤ 0. 25 μg/mL, SDD MIC = 0.5 μg/mL, R MIC ≥ 1 μg/mL) and AmB (ECV S MIC ≤ 2 μg/mL, R MIC > 2 μg /mL).
Statistical analyses
The Chi-square test (χ2) and the Student’s t test were used to compare the virulence data, resistance occurrence and mean MIC values of azoles, echinocandins, and AmB of C. albicans and C. catenulata from the three groups, respectively. A value of P < 0.05 was considered statistically significant.
Results
The PCR assay produced species-specific bands of the expected size (550 bp) for both C. albicans and C. catenulata strains, and sequence analysis confirmed the initial identification, based on colonial morphology, microscopic features and MALDI identification as C. albicans (accession numbers: KY101860, MH061333, MN419374) for 84 yeast isolates and C. catenulata (accession number: KY103373) for 17 yeast isolates.
A total of 80 C. albicans (95%) and 4 C. catenulata (23.5 %) strains showed phospholipase and haemolytic activities that differed according to the sample source, with the highest values recorded for C. albicans (Pz = 0.62, Hz = 0.49) in strains from group C and for C. catenulata (Pz = 0.54; Hz = 0.49) in strains from group A (Table 1).
High MIC values for azoles and AmB were recorded in all C. albicans strains from groups B and C (Table 2). C. catenulata showed high ITZ, POS ad VOR MIC values in strains from group B (faeces). ANI and MCF displayed the lowest MICs for both C. albicans and C. catenulata (Table 2). For C. catenulata, high MIC values for MCF (MIC 90 = 8) and ANI (MIC 90 = 8) were registered in strains from group C.
A relatively large number of C. albicans strains from groups B and C were resistant to azoles (i.e. from 30.7% for VOR to 92.3 % for POS in group B and from 50 to 100% for all azoles in group C). MCF resistance was observed in C albicans strains from group A (6%) and group C (50%) (Table 3). The drugs with the highest number of resistant C. albicans strains was POS (i.e. 83.6% strains in group A, 100% strains in groups B and C) followed by FLZ and ITZ (Table 3). All C. albicans strains were susceptible to ANI and AmB. A total of 21 C. albicans strains (15 from group A, 4 from group B and 2 from group C) were multidrug resistant, displaying resistance to FLC, ITZ, VOR, and POS. All C. catenulata strains from the group C were resistant to FLZ, ITZ, POS, MCF and ANI but susceptible to AmB (Table 3). C. catenulata strains from group A (40%) and group B (25%) were resistant to AmB.
Discussion
The results of this study demonstrate that C. albicans and C. catenulata isolated from cloacae, faeces and eggs of laying hens produce phospholipase and haemolysin and are resistant to azoles or AmB and echinocandin, thus highlighting the role of laying hens in harbouring and spreading pathogenic organisms in the environment. This finding is similar to that previously reported for strains from wild (Brilhante et al. 2013; Lord et al. 2010) or domesticated/pet birds (Subramanya et al. 2017; Ying and Chunyang 2012).
The production of phospholipase and proteinase has been shown to play a significant role in the pathogenesis and virulence of Candida species and related diseases (Dabiri et al. 2018). In addition, multidrug resistant yeasts often cause fatal infection in immunocompromised hosts (Mellinghoff et al. 2018). In this study, the virulence, azoles and echinocandins resistance profiles of yeasts varied according to the origin of Candida spp. In particular, for C. albicans, multidrug resistant strains were all isolated from the cloacae, faeces and eggs of laying hens, thus suggesting that the cloaca is the most likely source of multidrug resistance strains that are spread in the environment via the faeces or food. Resistance to azole derivatives is linked to changes in gene sequence or expression and appears to be linked to selective pressures induced by exposure to the azole products used in clinical practice or in agriculture (Brilhante et al. 2013; Brilhante et al. 2012; Pfaller 2012b). Since the animals from this study had no history of previous treatment with antifungal drugs, the drug-resistance detected in this study might be associated with the presence of these compounds in the feed or fruits administered to these animals, in accordance with previous reports (Subramanya et al. 2017; Brilhante et al. 2010; Brilhante et al. 2013). Long-term laboratory maintenance of microorganisms might influence the expression of some virulence factors; nevertheless, in this study, we observed that the virulence of Candida strains varied according to sample origin. In particular, the phospholipase and haemolytic activities of C. albicans were higher in strains isolated from eggs than those cloaca isolated ones. This finding might be linked to the extracellular enzymes secreted by C. albicans that might vary according to different host factors associated to the ecosystem within which the yeast resides (Gil-Bona et al. 2018). Thus, C. albicans might acquire virulence traits when in the environment or/and in eggs. For C. catenulata, the presence of drug resistance phenomena was most frequently observed among strains isolated from eggs. This finding might be due to a positive selection of the environment on the multidrug resistance of C. catenulata strains (Sidrim et al. 2010). However, C. catenulata strains from eggs are less able to produce phospholipase or protease, thus indicating a lower pathogenicity compared with the strains isolated from cloaca and suggesting a lower risk of human or animal infections posed from strains from the environment. Indeed, C. catenulata is a natural contaminant of dairy products but is nonetheless rarely associated with invasive or skin infection in human (Crozier and Coats 1977; Sârbu et al. 2013; Çakır et al. 2019; Ha et al. 2018; Radosavljevic et al. 1999).
In particular, even if > 106 C. catenulata CFU/gr have been detected in Australian Camembert or other European cheese (Roostita 1996), the yeast was identified as the causative agent in onychomycosis or vulvovaginal infections and in only three cases of candidaemia (i.e. in one patient with gastric cancer, in one hospitalised premature infant and in one cirrhotic patient with endocarditis) (Crozier and Coats 1977; Sârbu et al. 2013; Çakır et al. 2019; Ha et al. 2018; Radosavljevic et al. 1999).
However, even if C. catenulata is less pathogenic than C. albicans, its high distribution and low susceptibility to ITZ, POS, MCF and ANI as well as AmB might require a specific therapeutic protocol. A case of C. catenulata invasive infection was reported in a cancer patient that was successfully treated with intravenous AmB, following failed FLZ treatment (Radosavljevic et al. 1999). Nosocomial infections caused by Candida spp. have become more common in recent years, and those caused by non-albicans Candida spp. are rising proportionally more than those by C. albicans, being responsible for 35–65% of all candidaemia in the general patient population (Sharma et al. 2017). Food or beverages may act as sources of Candida spp. infection that, following ingestion, might enter the bloodstream and cause fungaemia (Benedict et al. 2016). Although clinical cases are rare and occur in unusual clinical circumstances, the presence of yeasts in food may be of significance. In the environment (faeces) or in eggs, C. albicans strains are more pathogenic and are characterised by protease and haemolysin production and azole resistance, whereas C. catenulata is characterised by a multidrug resistance profile. Interestingly, the high MIC values for AmB detected among C. albicans from faeces or eggs and in C. catenulata from cloaca swabs are in contrast with those previously reported for yeasts isolated from Agapornis birds and cockatiels that are bred under different conditions (Brilhante et al. 2010; Reis et al. 2018).
However, despite the high MIC values registered for AmB, resistance phenomena were detected only in C. catenulata from groups A and B, most likely due to the high value of ECV used (i.e. MIC > 2) or to the small number of samples tested. Since AmB and echinocandins are the first line of treatment for Candida fungaemia (Keane et al. 2018; Demir et al. 2019), resistance to these drugs should be not underestimated and needs to be further investigated using molecular approaches. The co-habitation of humans and laying hens and/or eggs may expose humans to multidrug-resistant and virulent yeasts. The breeding and handling of these animals may have consequently substantial implications for human and animal health. Therefore, high hygiene procedures in laying hens farm as well as the use of personal protective equipment might be important to prevent human (keepers/or visiting) and bird exposure to infectious propagules contaminating the environment and the eggs.
References
Antinori S, Corbellino M, Parravicini C (2018) Challenges in the diagnosis of invasive fungal infections in immunocompromised hosts. Curr Fungal Infect Rep 12(1):12–22
Benedict K, Chiller TM, Mody RK (2016) Invasive fungal infections acquired from contaminated food or nutritional supplements: a review of the literature. Food borne Pathog Dis 13(7):343–349
Brilhante RSN, Castelo-Branco DSCM, Soares GDP, Astete-Medrano DJ, Monteiro AJ, Cordeiro RA, Rocha MFG (2010) Characterization of the gastrointestinal yeast microbiota of cockatiels (Nymphicus hollandicus): a potential hazard to human health. J Med Microbiol 59(6):718–723
Brilhante RS, Paiva MA, Sampaio CM, Teixeira CE, Castelo-Branco DS, Leite JJ, Sidrim JJ (2011) Yeasts from Macrobrachium amazonicum: a focus on antifungal susceptibility and virulence factors of Candida spp. FEMS Microbiol Ecol 76(2):268–277
Brilhante RS, Castelo Branco DS, Duarte GP, Paiva MA, Teixeira CE, Zeferino JP, Rocha M (2012) F. Yeast microbiota of raptors: a possible tool for environmental monitoring. Environ. Microbiol. Rep. 4(2):189–193
Brilhante RSN, de Alencar LP, de Aguiar CR, Castelo DDSCM, Teixeira CEC, de Brito MR, de Oliveira MF (2013) Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health. J Med Microbiol 62(6):889–895
Cafarchia C, Romito D, Coccioli C, Camarda A, Otranto D (2008) Phospholipase activity of yeasts from wild birds and possible implications for human disease. Med Mycol 46(5):429–434
Cafarchia C, Iatta R, Danesi P, Camarda A, Capelli G, Otranto D (2018) Yeasts isolated from cloacal swabs, feces, and eggs of laying hens. Med Mycol 57(3):340–345
Çakır SÇ, Çelebi S, Özkan H, Köksal N, Dorum BA, Yeşil E, Hacımustafaoğlu M (2019) Results of the use of micafungin in newborns. Mikrobiyol Bul 53(1):70–80
CLSI DOCUMENT M27-A3. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard–third edition. 2008.
CLSI DOCUMENT M59: Epidemiological cut-off values for antifungal susceptibility testing. Clinical Laboratory Standards Institute, 2edition, 2018.
Crozier WJ, Coats H (1977) A case of onychomycosis due to Candida ravautii. Aust J Derm 18:139–140
Dabiri S, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M (2018) Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens. J Mycol Med 28(3):437–442
Demir KK, Butler-Laporte G, Lee TC, Cheng MP (2019) Comparative effectiveness of amphotericin B, azoles, and echinocandins in the treatment of candidemia and invasive candidiasis: A Systematic Review and Network Meta-Analysis. Open Forum Infect Dis (6):S716–S716
Elfeky DS, Gohar NM (2016) Evaluation of virulence factors of Candida species isolated from superficial versus systemic candidiasis. Egypt J Med Microbiol 38(87):1–10
Elhariri M, Hamza D, Elhelw R, Refai M (2015) Love birds and cockatiels risk reservoir of Cryptococcus neoformans, a potential hazard to human health. J Vet Sci Med Diagn 4:4–2
Gil-Bona A, Amador-García A, Gil C, Monteoliva L (2018) The external face of Candida albicans: a proteomic view of the cell surface and the extracellular environment. J Proteome 180:70–79
GunTang W, Kamonvoradej N, Chomchat C, Suriyakan S, Sanit S, Wongwigkarn J, Lamlertthon S (2017) Prevalence and virulence factors of Candida spp. associated with blow flies. Asian Pac. J. Trop. Biomed. 7(5):428–431
Ha MV, Choy MS, McCoy D, Fernandez N, Suh JS (2018) Candida catenulata candidaemia and possible endocarditis in a cirrhotic patient successfully de-escalated to oral fluconazole. J Clin Pharm Ther 43(6):910–913
Keane S, Geoghegan P, Povoa P, Nseir S, Rodriguez A, Martin-Loeches I (2018) Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis. Expert Rev Anti-Infect Ther 16(11):839–847
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Thompson JD (2007) Clustal W and Clustal X version 2.0. Bioinformatics. 23(21):2947–2948
Lord AT, Mohandas K, Somanath S, Ambu S (2010) Multidrug resistant yeasts in synanthropic wild birds. Ann Clin Microbiol Antimicrob 9(1):11
Mellinghoff SC, Cornely OA, Jung N (2018) Essentials in Candida bloodstream infection. Infection 46:897–899
Pfaller MA (2012a) Diekema DJ 2012. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 50:2846–2856
Pfaller MA (2012b) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3–S13
Price MF, Wilkinson ID, Gentry LO (1982) Plate method for detection of phospholipase activity in Candida albicans. Med Mycol 20:7–14
Radosavljevic M, Koenig H, Letscher-Bru V, Waller J, Maloisel F, Lioure B, Herbrecht R (1999) Candida catenulata fungemia in a cancer patient. J Clin Microbiol 37(2):475–477
Reis EJ, Buscariolo F, Siqueira JP, Castilho EM, Almeida MT (2018) Agapornis sp. pet birds: Source of dissemination of azole-resistant yeasts. Med Mycol 57(4):515–518
Roostita R, Fleet GH (1996) The occurrence and growth of yeasts in Camembert and Blue-veined cheeses. Int J Food Microbiol 28:393–404
Sârbu I, Pelinescu D, Stoica I, Măruţescu L, Vassu T (2013) Phenotypic profiles of virulence in different Candida species isolated from vulvovaginal infections. Roum Arch Microbiol Immunol 72(4):225–233
Sharma Y, Chumber SK, Kaur M (2017) Studying the prevalence, species distribution, and detection of in vitro production of phospholipase from Candida isolated from cases of invasive candidiasis. J Global Infect Dis 9:8–11
Sidrim JJC, de Souza Collares DCB, Brilhante RSN, Soares GDP, Cordeiro RA, Monteiro AJ, Rocha MFG (2010) Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): in vitro antifungal susceptibility profile and phospholipase activity. Vet Microbiol 145(3-4):324–328
Subramanya SH, Baral BP, Sharan NK, Nayak N, Metok Y, Sathian B, Gokhale S (2017) Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal. BMC Res Notes 10(1):543
Tscherner M, Giessen TW, Markey L, Kumamoto CA, Silver PA (2019) A synthetic system that senses Candida albicans and inhibits virulence factors. ACS Synth Biol 8(2):434–444
Tsiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME (2008) Human infections associated with wild birds. J Inf Secur 6(2):83–98
Ying S, Chunyang L (2012) Correlation between phospholipase of Candida albicans and resistance to fluconazole. Mycoses. 55:50–55
Funding
Open access funding provided by Università degli Studi di Bari Aldo Moro within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Contributions
Wafa Rhimi and Claudia Cafarchia conceptualised the study and wrote the manuscript. Wafa Rhimi and Chioma Inyang Aneke performed the research. Claudia Cafarchia, Giada Annoscia, Antonio Camarda, Adriana Mosca and Domenico Otranto contributed to analysis and interpretation of the study data. Claudia Cafarchia, Cinzia Cantacessi and Otranto Domenico revised, edited and made intellectual inputs in the manuscript. Cinzia Cantacessi revised the English version of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies performed by any of the authors with humans or animals participants.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rhimi, W., Aneke, C.I., Annoscia, G. et al. Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens. Int Microbiol 24, 57–63 (2021). https://doi.org/10.1007/s10123-020-00141-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10123-020-00141-1